12 By embracing these strategies, individuals using GLP-1 medications can optimize their results, minimize discomfort, and build a foundation for a healthier, more empowered future
Previous reports of reduced desire to smoke in patients treated with semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA) medication for type 2 diabetes mellitus and obesity, have raised interest about its potential benefit for tobacco use disorders
Measurement of gastric emptying rate in humans by real-time ultrasound
Compared with full basal-bolus insulin regimens, the combination of GLP-1 agonist plus insulin resulted in a marginal 0.1% reduction in HbA1c, a 33% lower risk of hypoglycaemia and a mean 5.66-kg reduction in weight
The effect of nitrate supplementation on exercise performance in healthy individuals: a systematic review and meta-analysis
He has a calm demeanor and takes the time to listen to his patients concerns, allowing him to build strong relationships which result in optimal care
